Aytu BioPharma Inc.

NASDAQ: AYTU
Share price (1/3/25): $1.77
Market cap (1/3/25): $10.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-Q 58 pages Asset Purchase Agreement Dated as of April 12, 2021 Among Aytu Biopharma, Inc., Rumpus Veds LLC, Rumpus Therapeutics LLC, Rumpus Vascular LLC, and Solely With Respect to Certain Provisions, Christopher Brooke and Nathaniel Massari

from 425 121 pages Agreement and Plan of Merger by and Among Aytu Bioscience, Inc., Neutron Acquisition Sub, Inc. and Neos Therapeutics, Inc. Dated as of December 10, 2020

from 8-K 121 pages Agreement and Plan of Merger by and Among Aytu Bioscience, Inc., Neutron Acquisition Sub, Inc. and Neos Therapeutics, Inc. Dated as of December 10, 2020

from 8-K 127 pages Asset Purchase Agreement Dated as of October 10, 2019 Between Aytu Bioscience, Inc. and Cerecor Inc

from 8-K 81 pages Agreement and Plan of Merger by and Among Aytu Bioscience Inc., Aytu Acquisition Sub, Inc. and Innovus Pharmaceuticals, Inc. Dated as of September 12, 2019

from 8-K 23 pages Certificate of Merger of Rosewind Merger Sub L, Inc. With and Into Luoxis Diagnostics, Inc. * * * * * * *

from 8-K 105 pages Agreement and Plan of Merger